Congestive heart failure was associated with 1.9 times greater muscle sympathetic nerve activity compared with healthy controls (P<0.001), correlating closely with heart rate and plasma norepinephrine.
Meta-Analysis (n=2,530)
Is muscle sympathetic nerve activity (MSNA) elevated in congestive heart failure patients compared to healthy controls, and does it correlate with disease severity and cardiac parameters?
Sympathetic overactivity in CHF mirrors the degree of LV dysfunction independently of the stage, cause, or pharmacological treatment, with plasma norepinephrine and HR serving as valuable surrogate markers.
Effect estimate: 1.9 times
p-value: p=<0.001
BACKGROUND AND OBJECTIVES: Sympathetic neural activation occurs in congestive heart failure (CHF). However, the small sample size of the microneurographic studies, heterogeneity of the patients examined, presence of comorbidities as well as confounders (including treatment) represented major weaknesses not allowing to identify the major features of the phoenomenon, particularly in mild CHF. This meta-analysis evaluated 2530 heart failure (CHF) patients recruited in 106 microneurographic studies. It was based on muscle sympathetic nerve activity (MSNA) quantification in CHF of different clinical severity, but data from less widely addressed conditions, such as ischemic vs. idiopathic, were also considered. METHODS: Assessment was extended to the relationships of MSNA with venous plasma norepinephrine, heart rate (HR) and echocardiographic parameters of cardiac morphology left ventricular (LV) end-diastolic diameter and function (LV ejection fraction) as well. RESULTS: MSNA was significantly greater (1.9 times, P < 0.001) in CHF patients as compared with healthy controls, a progressive significant increase being observed from New York Heart Association classes I-IV in unadjusted and adjusted analyses. MSNA was significantly greater in both untreated and treated CHF (P < 0.001 for both), related to left ventricular (LV) end-diastolic diameter and to a lesser extent to LV ejection fraction (r = 0.24 and -0.05, P < 0.001 and <0.01, respectively), and closely associated with HR (r = 0.66, P < 0.001) and plasma norepinephrine (r = 0.68, P < 0.001). CONCLUSION: CHF is characterized by sympathetic overactivity which mirrors the degree of LV dysfunction independently of the stage of CHF, its cause and presence of confounders or pharmacological treatment. plasma norepinephrine and HR represent potentially valuable surrogate markers of sympathetic activation in the clinical setting.
Grassı et al. (Mon,) conducted a meta-analysis in Congestive heart failure (CHF) (n=2,530). Congestive heart failure vs. Healthy controls was evaluated on Muscle sympathetic nerve activity (MSNA) (1.9 times, p=<0.001). Congestive heart failure was associated with 1.9 times greater muscle sympathetic nerve activity compared with healthy controls (P<0.001), correlating closely with heart rate and plasma norepinephrine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: